Ebenbuild, a company developing personalized, AI-driven virtual lungs to support clinical decisions and digital clinical trials, announced its participation in the research project Personalized Lung Twins for the Treatment of Acute Respiratory Distress Syndrome (UBIC) in collaboration with the University Hospital Schleswig-Holstein, Augsburg University Hospital, University Hospital Carl Gustav Carus Dresden, University Hospital RWTH Aachen and University Medical Center Mannheim.
The European start-up HealthSage AI announces the launch of its Open Source Generative AI Platform fully dedicated to healthcare: a trusted and transparent foundation for the development of AI applications for healthcare.
The first release of HealthSage AI's Large Language Model, Note-to-FHIR, transforms clinical notes and other types of unstructured text into a structured FHIR output.
Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline of its investigational contrast agent as well as new innovations in the area of Artificial Intelligence (AI).
Orion Health's UK and Ireland Customer Conference 2023 focused on the future potential and immediate, practical application of AI to healthcare - and gave delegates a first look at the Orchestral health intelligence platform that will support integrated care systems and trusts that want to get started.
CompuGroup Medical SE & Co. KGaA (CGM), one of the world's leading e-health providers, successfully progressed the digitization in healthcare during the first three quarters in 2023. CGM supports physicians to enable a fully digital patient journey by providing additional modules to process emergency data sets, electronic medication plan and handling e-health records.
The NHS exists to serve patients. But more could be done to make their experience a key focus when it comes to technology adoption, senior NHS delegates told a recent roundtable. SPARK TSL reports.
Sustained challenges faced by clinical teams on the frontline of an NHS under pressure are well documented in daily headlines.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received a second round of funding from the Bill & Melinda Gates Foundation to accelerate global adoption of AI algorithms on Philips Lumify Handheld Ultrasound. By using AI to simplify key measurements to identify abnormalities during